GB Sciences Inc (QB) (GBLX) Fundamentals

Description
GB Sciences, Inc. (OTCQB: GBLX) is a phytomedical research and biopharmaceutical drug development company whose goal is to create patented formulations of plant-inspired, complex therapeutic mixtures that target a variety of medical conditions.
Share Info
StatusActive
Market Cap$ 8,125,939
Shares Authorized600,000,000
Shares Outstanding325,037,557
Shares Outstanding Date06/03/2022
Shareholder Count183
Shareholder Count Date07/06/2021
Float276,636,933
Float Date07/02/2021
Short Interest48,648
Short Interest Date05/31/2022
Reporting Info
Reporting StatusSEC Reporting
BankruptNo
ShellNo
Audit StatusYes
AuditorAssurance Dimensions Inc
Auditor Address4920 W Cypress Street,
Suite 102
Tampa, Florida 33607
USA
Auditor Websitehttp://https://assurancedimensions.com/
IR Firm-
IR Firm Address-
IR Firm Website-
Legal CounselGary R Henrie - Attorney at Law
Legal Counsel Address619 South 1040 East
American Fork, Utah 84003
USA
Legal Counsel Website-
Fiscal Year End3/31
ADR Ratio-
Transfer AgentColonial Stock Transfer Co., Inc.
Transfer Agent Address7840 S. 700 E
Salt Lake City, UT 84070
USA
Depository Websitehttp://www.colonialstock.com
SHO Flag-
3210 Flag-
Company Info
Ticker SymbolUSOTC:GBLX
OTC Market TierOTCQB
Security TypeCommon Stock
CIK Number0001165320
Address3550 W. Teco Avenue
Las Vegas, Nevada 89118
CountryUSA
Phone(866) 721-0297
Fax #-
Websitehttp://www.gbsciences.com
SIC Code / Description1311 / Crude petroleum and natural gas
Key ExecutivesCFO - Zach Swarts
CEO - John Poss
President - Andrea Small-Howard
Dir. - Edmond DeFrank
Number of Employees5
Incorporation StateNevada
Incorporation CountryUSA
Incorporation Year2018


Your Recent History
USOTC
GBLX
GB Science..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.